667, L.P.
CIK 1551139 · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.75B
Companies
24
Total Filings
78
Lifetime Open-Market Net
$5.23B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | Director | 39,487,463 | $21.09 | $832.79M | $630.00M | 3 | 2026-06-02 |
| ONC | Director | 730,643 | $264.48 | $193.24M | -$1.57M | 2 | 2026-05-27 |
| TCRX | Director | — | $0.91 | — | $0 | 3 | 2026-05-22 |
| INCY | Director | 28,482,491 | $108.53 | $3.09B | $0 | 11 | 2026-05-11 |
| REPL | Director | — | $8.88 | — | $0 | 1 | 2026-04-07 |
| DBVT | Director | — | $17.41 | — | $0 | 1 | 2026-01-14 |
| KOD | Director | 18,358,772 | $34.06 | $625.30M | $650.35M | 7 | 2025-12-19 |
| DNLI | Director | — | $21.66 | — | $0 | 1 | 2025-12-15 |
| MDGL | Director | 1,832,216 | $480.77 | $880.87M | $196.74M | 3 | 2025-08-20 |
| VTVT | Director | — | $32.77 | — | $0 | 1 | 2025-06-12 |
| IMCR | Director | — | $28.96 | — | $0 | 1 | 2025-05-19 |
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 355,142 | $1.27 | $451.0K | $0 | 9 | 2025-01-03 |
| BCYC | Director | 8,666,247 | $4.05 | $35.10M | $127.38M | 2 | 2024-12-17 |
| PRLD | Director | — | $4.49 | — | $0 | 2 | 2024-06-18 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 126,096 | $184.71 | $23.29M | $3.77B | 2 | 2024-06-07 |
| NGNE | Director | 39,081 | $29.10 | $1.14M | $0 | 1 | 2023-12-20 |
| Talis Biomedical Corp (TLIS) Delisted | Director | — | $2.84 | — | $0 | 1 | 2023-06-13 |
| KNSA | Director | 132,566 | $51.89 | $6.88M | $0 | 2 | 2023-06-08 |
| Seagen Inc. (SGEN) Delisted | Director | 43,000,581 | $228.74 | $9.84B | $180.65M | 5 | 2023-06-02 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 1 | 2021-05-13 |
| ZYME | Director | — | $22.88 | — | $0 | 1 | 2020-05-12 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 157,519 | — | — | -$482.48M | 10 | 2019-04-12 |
| Aceragen, Inc. (IDRA) Delisted | Director | 154,498 | $7.22 | $1.12M | $224.00M | 4 | 2018-06-21 |
| XOMA | Director | 2,089,012 | $41.79 | $87.30M | -$59.06M | 1 | 2015-01-06 |
Recent Filings · Page 2 of 8
78 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-12 | VTVT | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | ONC | Grant (A) | +263,640 | $0 | EDGAR |
| 2025-05-19 | IMCR | Grant (A) | — | $0 | EDGAR |
| 2025-01-03 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +23,928 | $0 | EDGAR |
| 2024-12-17 | BCYC | Buy (P) | +8,912,382 | $127.38M | EDGAR |
| 2024-10-02 | INCY | Grant (A) | +5,952 | $0 | EDGAR |
| 2024-07-02 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | +23,928 | $0 | EDGAR |
| 2024-06-20 | BCYC | Conv (C) | +14,296,704 | $0 | EDGAR |
| 2024-06-18 | PRLD | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | TCRX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.